Showing results (191-200 of 219) with videos related to

Sort By:
Pageof 22
Urologic Oncology|June 21, 2015
Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non-castration-resistant prostate cancerPrabhakar Rajan, John A Frew, James M Wilson, et al.
Pediatric Nephrology (Berlin, Germany)|September 19, 2024
Effect of perioperative management on early graft function in living donor paediatric kidney transplantationJennifer Q J Zhang, Elena Cavazzoni, Anne M Durkan, et al.
Nuclear Medicine and Biology|February 1, 2014
A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumorsKubra Durkan, Zongrun Jiang, Tammy L Rold, et al.
Diabetes Research and Clinical Practice|June 6, 2022
Serum OPG/TRAIL ratio predicts the presence of cardiovascular disease in people with type 2 diabetes mellitusH Forde, C Davenport, K D Rochfort, et al.
Irish Journal of Medical Science|July 23, 2013
Audit of rapid access introduction reveals high prevalence of prostate cancer in Western RegionE M Bolton, B D Kelly, M R Quinlan, et al.
Journal of Viral Hepatitis|November 21, 2017
Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE studyA Brown, C Hézode, E Zuckerman, et al.
Internal Medicine Journal|March 28, 2018
Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New ZealandLucy C Fox, Solomon J Cohney, Joshua Y Kausman, et al.
International Journal of Clinical and Experimental Pathology|February 16, 2013
Daedalic DNA vaccination against self antigens as a treatment for chronic kidney diseaseYuan Min Wang, Jimmy Jianheng Zhou, Ya Wang, et al.
BJU International|February 3, 2016
European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional studyRobert W Foley, Robert M Maweni, Laura Gorman, et al.
Plos One|April 12, 2018
DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in miceJimmy Jianheng Zhou, Yuan Min Wang, Vincent W S Lee, et al.
Pageof 22